Indications and uses
Use on affected areas to clear and prevent breakouts. Suitable for use on the face and body
Use on affected areas to clear and prevent breakouts. Suitable for use on the face and body
Use morning and night After cleansing with Natralia Acne Wash , cover the entire affected area with a thin layer of Natralia Acne Cream.
Store between 50°- 86°F in a dry place.
Drug Facts
| Active ingredients | Purpose |
|---|---|
| Calcarea Carbonica (3× HPUS 0.5%)* | Acne Control |
| Pulsatilla Vulgaris (3× HPUS 0.5%)* | Acne Control |
| Calendula Officinalis (6× HPUS 1%)* | Acne Control |
* The letters H.P.U.S. indicate that the components in this product are officially monographed in the Homeopathic Pharmacopoeia of the United States.
Capric/Caprylic Triglycerides, Caprylyl Glycol (and) Sorbic Acid (and) Phenoxyethanol, Cetyl Palmitate (and) Sorbitan Palmitate (and) Sorbitan Olivate, Chamomilla Recutita (Chamomile) Extract, Garcinia Mangostana Extract, Glycerine, Glyceryl Stearate, Hamamelis Virginiana (Witch Hazel) Distillate, Hydroxyethyl Acrylate/Sodium Acryloyldimethyltaurate Copolymer (and) Squalane (and) Polysorbate 60, Lactic Acid, Melaleuca Alternifolia (Tea Tree) Oil, Rosa Canina Fruit (Rose Hip) Oil, Sodium Hydroxide, Stearic Acid, Water, Zinc PCA
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| bee4fa8d-8d82-423a-a0b5-40a89dd13a99 | Product name | 1 | 20250618 |
| e0d2eb29-08bd-4bba-90d1-c91c68a38767 | Product name | 4 | 20250516 |
| 30b0ac6e-02aa-0e5c-0d8b-cffdf3a282b2 | Product name | 5 | 20250304 |
| 334fe8d2-68fb-4331-a576-420e302ec069 | Product name | 7 | 20240320 |
| f52be47f-7aa7-46c0-b1fa-50c18dd50206 | Product name | 1 | 20201029 |
| 444b3e50-f226-46ef-bfca-2e7035d140cd | Product name | 1 | 20190611 |
| e92765c1-be81-432a-b909-1b10777ec378 | Product name | 1 | 20190208 |
| 7cda52fc-125f-421c-8fea-bc1974370c49 | Product name | 2 | 20180703 |
| d5e51f11-ad28-caa4-4b49-4143974782ad | Product name | 1 | 20150831 |
| 0ca1d589-929b-4b33-bc5b-1d84abdafa6a | Product name | 1 | 20150324 |
| fc363c46-397b-4476-ac0f-70e43e8e4592 | Product name | 1 | 20150324 |
| 0441a8f5-3835-497c-aedd-bc78cba56b2a | Product name | 1 | 20150317 |
| 597b1cfd-7b31-5048-62be-ca5cd740da2f | Product name | 1 | 20140508 |
| 87711080-88eb-65c5-b2dd-bf99e700a372 | Product name | 1 | 20140508 |
| ec2149b3-5c6d-5344-f757-c86411073075 | Product name | 1 | 20140508 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 43251-3333-6 | 2019-11-27 | C162847 | 48780-1 | 9855d018-e174-cd31-e053-dbdaa90ab51a | natralia™ NATURALLY AUSTRALIAN acne cream |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 43251-3333-6 | Natralia Acne | 56 g in 1 BOTTLE, DISPENSING | CREAM | 56 | 3 | |
| 43251-3333-6 | Natralia Acne | 1 in 1 CARTON | CREAM | 1 | 3 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 43251-3333 | NATRALIA ACNE (CALENDULA OFFICINALIS FLOWER, CALCIUM CARBONATE, AND PULSATILLA VULGARIS) CREAM [LACORIUM HEALTH INTERNATIONAL PTY LTD] | 3 | Legacy NDC, 2 package rows | 20121222_bffc2c30-1b74-4475-997a-34debbcba696.zip |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| CALCIUM CARBONATE | ACTIVE INGREDIENT | H0G9379FGK | 3 | |
| CALENDULA OFFICINALIS FLOWER | ACTIVE INGREDIENT | P0M7O4Y7YD | 3 | |
| PULSATILLA VULGARIS | ACTIVE INGREDIENT | I76KB35JEV | 3 | |
| CALCIUM CATION | ACTIVE MOIETY | 2M83C4R6ZB | 3 | |
| CALENDULA OFFICINALIS FLOWER | ACTIVE MOIETY | P0M7O4Y7YD | 3 | |
| PULSATILLA VULGARIS | ACTIVE MOIETY | I76KB35JEV | 3 | |
| Caprylyl Glycol | INACTIVE INGREDIENT | 00YIU5438U | 3 | |
| Cetyl Palmitate | INACTIVE INGREDIENT | 5ZA2S6B08X | 3 | |
| Chamomile | INACTIVE INGREDIENT | FGL3685T2X | 3 | |
| Glycerin | INACTIVE INGREDIENT | PDC6A3C0OX | 3 | |
| Glyceryl Monostearate | INACTIVE INGREDIENT | 230OU9XXE4 | 3 | |
| Lactic Acid | INACTIVE INGREDIENT | 33X04XA5AT | 3 | |
| Phenoxyethanol | INACTIVE INGREDIENT | HIE492ZZ3T | 3 | |
| Polysorbate 60 | INACTIVE INGREDIENT | CAL22UVI4M | 3 | |
| Rosa Canina Fruit Oil | INACTIVE INGREDIENT | CR7307M3QZ | 3 | |
| Sorbic Acid | INACTIVE INGREDIENT | X045WJ989B | 3 | |
| Sorbitan Monopalmitate | INACTIVE INGREDIENT | 77K6Z421KU | 3 | |
| Sorbitan Olivate | INACTIVE INGREDIENT | MDL271E3GR | 3 | |
| Squalane | INACTIVE INGREDIENT | GW89575KF9 | 3 | |
| Stearic Acid | INACTIVE INGREDIENT | 4ELV7Z65AP | 3 | |
| Tea Tree Oil | INACTIVE INGREDIENT | VIF565UC2G | 3 | |
| Witch Hazel | INACTIVE INGREDIENT | 101I4J0U34 | 3 | |
| Zinc Pidolate | INACTIVE INGREDIENT | C32PQ86DH4 | 3 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 43251-3333 | 43251-3333-6 |
Every source-derived ingredient row is available through these pages.
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Lactic Acid | LACTIC ACID | 33X04XA5AT | GEL / TOPICAL | 30 mg | ||
| Stearic Acid | STEARIC ACID | 4ELV7Z65AP | AEROSOL, FOAM / TOPICAL | 8 %w/w | ||
| Stearic Acid | STEARIC ACID | 4ELV7Z65AP | EMULSION / TOPICAL | NA | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SUSPENSION/ DROPS / ORAL | 750 mg | ||
| Squalane | SQUALANE | GW89575KF9 | POWDER / ORAL | 0.02 mg | ||
| Cetyl Palmitate | CETYL PALMITATE | 5ZA2S6B08X | OINTMENT / TOPICAL | NA | ||
| Glyceryl Monostearate | GLYCERYL MONOSTEARATE | 230OU9XXE4 | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | 23 mg | ||
| Polysorbate 60 | POLYSORBATE 60 | CAL22UVI4M | AEROSOL, FOAM / TOPICAL | 30 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | INJECTION / INTRADERMAL | 1.6 %w/v | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SPRAY / NASAL | 22.3 mg/1ml | ||
| Glyceryl Monostearate | GLYCERYL MONOSTEARATE | 230OU9XXE4 | LOTION / TOPICAL | 177 mg | ||
| Sorbic Acid | SORBIC ACID | X045WJ989B | TABLET, FILM COATED / ORAL | 5 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SYSTEM / IONTOPHORESIS | 168.1 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | INJECTION, SOLUTION / SUBCUTANEOUS | 15 %w/v | ||
| Glyceryl Monostearate | GLYCERYL MONOSTEARATE | 230OU9XXE4 | TABLET, EXTENDED RELEASE / ORAL | 529 mg | ||
| Sorbitan Monopalmitate | SORBITAN MONOPALMITATE | 77K6Z421KU | LOTION / TOPICAL | 20 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SYSTEM / TOPICAL | 18144 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | LIQUID / TOPICAL | 2.5 %w/w | ||
| Glyceryl Monostearate | GLYCERYL MONOSTEARATE | 230OU9XXE4 | CAPSULE / ORAL | 13.75 mg | ||
| Sorbic Acid | SORBIC ACID | X045WJ989B | SYRUP / ORAL | 80 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | INJECTION, EMULSION / INTRAVENOUS | 24100 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | GEL / OPHTHALMIC | 0.88 %w/w | ||
| Glyceryl Monostearate | GLYCERYL MONOSTEARATE | 230OU9XXE4 | TABLET / ORAL | 33.34 mg | ||
| Phenoxyethanol | PHENOXYETHANOL | HIE492ZZ3T | AEROSOL, FOAM / TOPICAL | 72 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | JELLY / TOPICAL | NA | ||
| Sorbic Acid | SORBIC ACID | X045WJ989B | GEL / TOPICAL | 2 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | FILM, EXTENDED RELEASE / TRANSDERMAL | 306.2 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | INJECTION, SOLUTION / INTRAMUSCULAR | 15 %w/v | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | OINTMENT / TOPICAL | NA | ||
| Stearic Acid | STEARIC ACID | 4ELV7Z65AP | TABLET, EXTENDED RELEASE / ORAL | 200 mg | ||
| Lactic Acid | LACTIC ACID | 33X04XA5AT | CONCENTRATE / ORAL | 50 mg/5ml | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | DOUCHE / VAGINAL | 1 %w/w | ||
| Sorbic Acid | SORBIC ACID | X045WJ989B | TABLET / ORAL | 10 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | LIQUID / ORAL | 2400 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | AEROSOL, FOAM / TOPICAL | 21 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION / DENTAL | 15 %w/v | ||
| Stearic Acid | STEARIC ACID | 4ELV7Z65AP | SOAP / TOPICAL | 6 %w/w | ||
| Stearic Acid | STEARIC ACID | 4ELV7Z65AP | SHAMPOO / TOPICAL | 9.7 %w/w | ||
| Polysorbate 60 | POLYSORBATE 60 | CAL22UVI4M | EMULSION / ORAL | 20 mg/1ml | ||
| Glyceryl Monostearate | GLYCERYL MONOSTEARATE | 230OU9XXE4 | CAPSULE, EXTENDED RELEASE / ORAL | 32.4 mg | ||
| Phenoxyethanol | PHENOXYETHANOL | HIE492ZZ3T | AEROSOL / TOPICAL | 1.05 %w/w | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | GEL / TRANSDERMAL | 500 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | PASTE / ORAL | 3822 mg | ||
| Stearic Acid | STEARIC ACID | 4ELV7Z65AP | POWDER, FOR SUSPENSION / ORAL | 1203 mg/5ml | ||
| Polysorbate 60 | POLYSORBATE 60 | CAL22UVI4M | SHAMPOO / TOPICAL | 14.55 %w/w | ||
| Lactic Acid | LACTIC ACID | 33X04XA5AT | CREAM / TOPICAL | 1 %w/w | ||
| Polysorbate 60 | POLYSORBATE 60 | CAL22UVI4M | TABLET, COATED / ORAL | NA | ||
| Sorbic Acid | SORBIC ACID | X045WJ989B | AEROSOL, FOAM / TOPICAL | 6 mg | ||
| Glyceryl Monostearate | GLYCERYL MONOSTEARATE | 230OU9XXE4 | CREAM / VAGINAL | 140 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION / OPHTHALMIC | 6 %w/v | ||
| Stearic Acid | STEARIC ACID | 4ELV7Z65AP | TABLET, FILM COATED / ORAL | 176 mg | ||
| Sorbic Acid | SORBIC ACID | X045WJ989B | CONCENTRATE / ORAL | 1 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | CLOTH / TOPICAL | 0.05 mg/mg | ||
| Sorbitan Monopalmitate | SORBITAN MONOPALMITATE | 77K6Z421KU | SYSTEM / TOPICAL | 10.5 mg | ||
| Sorbic Acid | SORBIC ACID | X045WJ989B | TABLET / SUBLINGUAL | 0.16 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | LOTION / TOPICAL | 3990 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | FILM, EXTENDED RELEASE / BUCCAL | 34 mg | ||
| Lactic Acid | LACTIC ACID | 33X04XA5AT | INJECTION / SUBCUTANEOUS | 10 mg | ||
| Stearic Acid | STEARIC ACID | 4ELV7Z65AP | LOTION / TOPICAL | 80 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | INJECTION, SUSPENSION / SUBCUTANEOUS | 1.6 %w/v |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| b6a21ed9-7bb4-4fc5-b9be-d4b16eabe1fd | bffc2c30-1b74-4475-997a-34debbcba696 | 2012-12-19 | Warnings | b6a21ed9-7bb4-4fc5-b9be-d4b16eabe1fd bffc2c30-1b74-4475-997a-34debbcba696 |
Adverse event summaries are temporarily unavailable. Other product information remains available.